Location History:
- Prague, CZ (1990)
- Praha, CZ (1993)
Company Filing History:
Years Active: 1990-1993
Title: Antonin Sturc: Innovator in Peptide Chemistry
Introduction
Antonin Sturc is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of peptide chemistry, holding 2 patents that focus on innovative solutions for medical applications. His work emphasizes the development of compositions that can effectively treat conditions such as peptic ulcers.
Latest Patents
Sturc's latest patents include a cell-protective composition designed for preventing or treating peptic ulcers. This composition utilizes the cyclo-(1-alanyl-amino-1-cyclopentanecarbonyl)cyclodipeptide as a physiologically active component. It is intended for administration via oral or parenteral routes, demonstrating substantial non-toxicity and good tolerance, even at low dosage levels. Another significant patent involves peptide derivatives and processes for their preparation. This patent describes how peptide ester and amide derivatives can be converted into pharmacodynamically active spirocyclic peptide derivatives through enzymic hydrolysis and spontaneous cyclization, acting as drug precursors with prolonged biological effects.
Career Highlights
Throughout his career, Antonin Sturc has worked with several prominent companies, including Spofa, Spojene Podniky Pro, and Spojene Podniky Pro Zdravotnickou Vyrobu. His experience in these organizations has contributed to his expertise in the field of peptide chemistry and drug development.
Collaborations
Sturc has collaborated with notable colleagues such as Evzen Kasafirek and Ivan Krejci. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in his field.
Conclusion
Antonin Sturc's contributions to peptide chemistry and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to influence the development of effective treatments for various health conditions.